Literature DB >> 23256897

Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice.

Mara Kornete1, Hugues Beauchemin, Constantin Polychronakos, Ciriaco A Piccirillo.   

Abstract

Type 1 diabetes (T1D) results from a T cell dependent, autoimmune destruction of insulin producing beta cells in pancreatic islets of Langerhans, which results in insulin deficiency despite attempts at beta cell replacement by the emergence of newly-differentiated beta cells throughout T1D development. The origin of these cells has been difficult to assess as these are rapidly destroyed by the underlying autoimmunity. The identification of islets of Langerhans is typically assessed by either immunochemistry or immunofluorescence using antibodies directed against the different signature hormones and surface markers of various endocrine cells. However, the limited number of markers that can be used simultaneously and the uneven spatial distribution of endocrine cells within islets, limit the use of these histological analyses. To circumvent these caveats, we developed a novel approach using multi-parametric flow cytometry to assess the phenotype and function of pancreatic islet cell populations throughout T1D development. Using such strategy, we show that while beta cells undergo autoimmune destruction, insulin-producing cells arise from trans-differentiated alpha or delta cells, an outcome that was not solely the result of beta cell self-renewal. Moreover, we show that CD4(+)T cell-mediated inflammation correlates with the emergence of this insulin-producing beta cell-like cell.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23256897     DOI: 10.3109/08916934.2012.752462

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  5 in total

Review 1.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

Review 2.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

3.  Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.

Authors:  Mara Kornete; Edward S Mason; Julien Girouard; Erin I Lafferty; Salman Qureshi; Ciriaco A Piccirillo
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

4.  Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes.

Authors:  Esma S Yolcu; Haval Shirwan; Nadir Askenasy
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

5.  Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes.

Authors:  James Dooley; Lei Tian; Susann Schonefeldt; Viviane Delghingaro-Augusto; Josselyn E Garcia-Perez; Emanuela Pasciuto; Daniele Di Marino; Edward J Carr; Nikolay Oskolkov; Valeriya Lyssenko; Dean Franckaert; Vasiliki Lagou; Lut Overbergh; Jonathan Vandenbussche; Joke Allemeersch; Genevieve Chabot-Roy; Jane E Dahlstrom; D Ross Laybutt; Nikolai Petrovsky; Luis Socha; Kris Gevaert; Anton M Jetten; Diether Lambrechts; Michelle A Linterman; Chris C Goodnow; Christopher J Nolan; Sylvie Lesage; Susan M Schlenner; Adrian Liston
Journal:  Nat Genet       Date:  2016-03-21       Impact factor: 38.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.